General information

Alzheimer's Research & Therapy is essential reading for all life scientists and medical specialists as the major forum for translational research into Alzheimer’s disease, from graduate level and above.

All of the research articles in Alzheimer's Research & Therapy are open access; however the journal also publishes a range of additional article types which are only available by subscription. Article types include:

  • Reviews: provide a factual account of recent developments within an area of research. In-depth reviews provide substantial coverage of a subject in a single longer article, and multi-author thematic series explore a subject in a series of concise, narrowly focused review articles coordinated by a leading authority in the field.
  • Commentaries: short, focused and opinionated articles of contemporary interest on any subject within the journal's scope.
  • Meeting Reports: short descriptions of a conference that an author has attended, which should focus on the key developments presented and discussed at the meeting.
  • Viewpoints: short opinion pieces focusing on the latest high-impact research.

A 30-day free trial enables access to all content published in Alzheimer's Research & Therapy. During this time, readers can freely access the most recent commentaries, viewpoints, reviews and meeting reports and stay up-to-date with the latest in dementia research.

Registration is required in order to activate a free trial.

If you are already registered, you will need to login in order to be able to activate your free trial.